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Following  transmission,  HIV-1  adapts  in the  new host  by acquiring  mutations  that  allow  it  to  escape
from  the  host  immune  response  at multiple  epitopes.  It also reverts  mutations  associated  with  epitopes
targeted  in  the  transmitting  host  but  not  in  the  new  host.  Moreover,  escape  mutations  are  often  associ-
ated  with  additional  compensatory  mutations  that  partially  recover  ﬁtness  costs.  It is  unclear  whether
recombination  expedites  this  process  of  multi-locus  adaptation.  To  elucidate  the  role  of  recombina-
tion,  we constructed  a  detailed  population  dynamics  model  that integrates  viral  dynamics,  host  immune
response  at  multiple  epitopes  through  cytotoxic  T lymphocytes,  and viral  evolution  driven  by mutation,
recombination,  and  selection.  Using  this  model,  we  compute  the expected  waiting  time  until  the  emer-
gence  of the strain  that  has  gained  escape  and  compensatory  mutations  against  the  new  host’s  immune
response,  and reverted  these  mutations  at epitopes  no longer  targeted.  We  ﬁnd  that depending  on  the
underlying  ﬁtness  landscape,  shaped  by  both  costs  and  beneﬁts  of mutations,  adaptation  proceeds  via
distinct  dominant  pathways  with  different  effects  of  recombination,  in particular  distinguishing  escape
and  reversion.  When  adaptation  at a single  epitope  is  involved,  recombination  can  substantially  acceler-
ate  immune  escape  but minimally  affects  reversion.  When  multiple  epitopes  are  involved,  recombination
can  accelerate  or  inhibit  adaptation  depending  on the  ﬁtness  landscape.  Speciﬁcally,  recombination  tends
to  delay  adaptation  when  a  purely  uphill  ﬁtness  landscape  is accessible  at each  epitope,  and  accelerate
it  when  a ﬁtness  valley  is  associated  with  each  epitope.  Our  study  points  to the  importance  of  recombi-
nation  in  shaping  the  adaptation  of  HIV-1  following  its transmission  to new hosts,  a  process  central  to  T
cell-based  vaccine  strategies.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Cytotoxic CD8+ T lymphocytes (CTLs) mount a powerful
esponse to transmitted HIV in the acute phase of infection and
imit its spread within infected individuals (Walker and McMichael,
012). The CTL response, however, is inadequate to eradicate the
irus. HIV evolves to escape this CTL pressure and invariably estab-
ishes persistent infection. Understanding the forces driving this
rms race between HIV and the early immune response is crucial
o the design of preventive vaccines (McMichael et al., 2010; Walker
nd McMichael, 2012). Recent advances in genomic sequencing
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technologies have yielded unprecedented insights into the nature
of this arms race (Keele et al., 2008; Goonetilleke et al., 2009;
Salazar-Gonzalez et al., 2009; Fischer et al., 2010; Henn et al., 2012;
Liu et al., 2013). First, in a majority of infected individuals, a single
founder strain of the virus is observed to establish infection (Keele
et al., 2008; Salazar-Gonzalez et al., 2009; Fischer et al., 2010; Henn
et al., 2012). Second, multiple epitopes on the virus are targeted by
CTLs, each epitope typically by a distinct CTL clone (Goonetilleke
et al., 2009; Henn et al., 2012; Liu et al., 2013). Third, the diver-
sity of the virus in regions targeted by CTLs increases signiﬁcantly
compared to regions not targeted by CTLs, presenting evidence that
early viral evolution is in response to CTL pressure (Henn et al.,
2012; Liu et al., 2013). Fourth, immune escape mutations accumu-
late and get ﬁxed at many of these epitopes, subverting CTL activity
(Goonetilleke et al., 2009; Henn et al., 2012). Fifth, some regions not
targeted by CTLs also evolve (Goonetilleke et al., 2009; Henn et al.,
2012; Liu et al., 2013). Since different individuals, depending on
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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heir HLA types, target different HIV-1 epitopes, this latter evolu-
ion often represents reversion of immune escape mutations in the
ransmitted strain at epitopes targeted in the donor but not in the
ecipient (Leslie et al., 2004; Crawford et al., 2007; Chopera et al.,
008; Schneidewind et al., 2009). Immune escape typically incurs
 ﬁtness cost, which such reversions serve to recover (Friedrich
t al., 2004; Leslie et al., 2004). The emerging paradigm of early HIV
daptation is thus one of rapid, multi-site, targeted evolution on a
andscape determined by a convolution of intrinsic viral replicative
tness and CTL pressure.
The large mutation rate of HIV coupled with its massive turnover
ate allows the rapid emergence of mutant genomes that could
rive early viral adaptation (Cofﬁn, 1995; Perelson et al., 1996;
owak and May, 2000). Two factors, however, pose limits on such
utation-driven evolution. First, at each epitope, evolution may
ave to pass through a ﬁtness valley. The mutation on the epitope
hat confers immune escape often compromises the intrinsic ﬁt-
ess of the virus (Fernandez et al., 2005; Martinez-Picado et al.,
006; Schneidewind et al., 2007; Goepfert et al., 2008; Troyer et al.,
009; Crawford et al., 2009; Miura et al., 2009a,b, 2010). A sec-
nd, compensatory mutation may  arise to restore this ﬁtness at
east in part (Kelleher et al., 2001; Brockman et al., 2007; Crawford
t al., 2007, 2011; Schneidewind et al., 2007, 2008; Wright et al.,
012; Liu et al., 2014). Such compensatory mutations are how-
ver also expected to lower viral ﬁtness when alone (Schneidewind
t al., 2007; Althaus and De Boer, 2008; Hinkley et al., 2011; Wright
t al., 2012), though in some cases they may  be neutral (Liu et al.,
014). That is, the escape and compensatory mutations exhibit pos-
tive epistasis and confer a ﬁtness advantage together, but strains
arrying either mutation alone may  be poorly competitive against
he non-mutant strain. Consequently, the frequencies of these sin-
le mutant strains are low, limiting the occurrence of the second
utation on these strains. Second, because multiple epitopes are
imultaneously targeted by CTLs, the accumulation of the escape
nd compensatory mutations at each of these epitopes onto a single
iral genome is inhibited by ‘clonal interference’ in ﬁnite popu-
ations (Gerrish and Lenski, 1998; da Silva, 2012; Ganusov et al.,
013; Kessinger et al., 2013; Leviyang, 2013; Garcia and Regoes,
014). Clonal interference is illustrated by the hypothetical scenario
here CTLs target two epitopes, and viral genomes carrying escape
nd compensatory mutations to each but not both epitopes exist.
omplete escape from CTL pressure would require accumulation of
hese mutations on a single genome. Until then, however, compe-
ition between the strains tends to drive the less ﬁt strain extinct.
 study of acutely infected HIV patients revealed a median of eight
pitopes targeted by CTLs 2–3 months after the onset of symptoms
Turnbull et al., 2009). Under the simple assumption of one escape
nd one compensatory mutation per epitope, this would suggest
hat ∼16 mutations must accumulate for optimal adaptation of HIV
o the CTL response within the ﬁrst few months, and, if the previous
ost targeted completely different epitopes, potentially an equiv-
lent number of reversions. Given the intrinsic mutation rate of
IV in vivo and the size of the infected cell pool, genomes carrying
ore than two mutations on the ﬁttest genome are unlikely to exist
n the viral quasispecies (Gao and Wang, 2007; Gadhamsetty and
ixit, 2010; Pennings, 2012), requiring such accumulation to occur
equentially, with intermediate strains left vulnerable to immune
ttack. The waiting time for the sequential accumulation of all of
hese mutations may  thus be large. Recombination, which can bring
ogether mutations on distinct viral genomes, may  allow HIV to
vercome these limitations and adapt rapidly. That recombination
an help overcome clonal interference has been recognized earlier
s the Fisher–Muller effect (e.g., see Kim and Orr, 2005).
Recombination occurs during reverse transcription of viral RNA
n an infected cell when the HIV enzyme reverse transcriptase
witches templates between the two strands of the viral RNAics 14 (2016) 11–25
contained in the infecting virion and produces a proviral DNA  that
is a mosaic of the two strands. The crossover frequency of the
HIV reverse transcriptase is ∼10 per genome per reverse tran-
scription, an order of magnitude larger than the HIV mutation
rate (Levy et al., 2004; Suryavanshi and Dixit, 2007). Speciﬁcally,
if one of the two strands contains an escape mutation on one epi-
tope and the other on another epitope, recombination can yield
a genome carrying escape mutations on both epitopes. Similarly,
recombination has been shown to accelerate the accumulation of
drug resistance mutations (Moutouh et al., 1996). However, the
beneﬁt of recombination to HIV is not clear for the following rea-
sons. First, just as recombination can bring mutations together,
it can also drive them apart. In particular, when ﬁtness interac-
tions between mutations exhibit positive epistasis, recombination
is expected to decelerate the growth of strains carrying multiple
mutations (Bonhoeffer et al., 2004; Bretscher et al., 2004). Second,
recombination can inﬂuence genomic diversiﬁcation only when the
two genomic strands in a virion are not identical; i.e., the virion is
heterozygous (Rhodes et al., 2003). The production of heterozy-
gous virions requires cellular superinfection, which appears not
to be frequent: recent studies suggest that ∼10% of infected cells
carry more than one provirus (Josefsson et al., 2011, 2013), argu-
ing for a limited role of recombination (Neher and Leitner, 2010;
Batorsky et al., 2011). The inﬂuence of recombination then depends
on several factors including the frequency of multiple infections of
cells, stochastic effects from ﬁnite populations, epistatic interac-
tions between escape mutations, and the number of loci involved
(Boerlijst et al., 1996; Otto and Lenormand, 2002; Bretscher et al.,
2004; Althaus and Bonhoeffer, 2005; Bocharov et al., 2005; Fraser,
2005; Rouzine and Cofﬁn, 2005, 2010; Kouyos et al., 2006, 2007;
Gheorghiu-Svirschevski et al., 2007; Hartl and Clark, 2007; Dixit,
2008; Vijay et al., 2008; Arora and Dixit, 2009; Batorsky et al., 2011;
Mostowy et al., 2011; Moradigaravand et al., 2014). Broadly, recom-
bination can differentially inﬂuence the dynamics of adaptation and
the equilibrium frequencies of mutant strains (reviewed, for exam-
ple, in Dixit, 2008). It is a basic result of population genetics that
recombination lowers the magnitude of linkage disequilibrium.
In a two-locus/two-allele model, when recombination lowers the
extent of negative linkage disequilibrium, the equilibrium fre-
quency of double mutants rises and increases genomic diversity.
The opposite happens when recombination lowers positive linkage
disequilibrium. Linkage disequilibrium depends on epistatic inter-
actions between loci and on random genetic drift determined by the
effective population size. Speciﬁcally, random genetic drift intro-
duces negative linkage disequilibrium (the Hill–Robertson effect
(Hill and Robertson, 1966)), allowing recombination to increase
diversity with small effective population sizes. With large popu-
lation sizes, linkage disequilibrium tends to have the same sign
as epistasis. Moreover, in the two-locus/two-allele model, recom-
bination invariably expedites the ﬁrst appearance of the strain
that carries both mutations, but may  decelerate its subsequent
growth as described above. With more than two loci, the inﬂuence
of recombination is thus more difﬁcult to predict: recombination
may  either accelerate or decelerate the emergence and ﬁxation of
higher-order mutants depending on its inﬂuence on the emergence
and growth of lower-order mutants. The conditions under which
recombination accelerates adaptation at multiple loci thus remain
to be clariﬁed.
Several previous studies have used mathematical models to
investigate whether recombination is expected to accelerate or
decelerate the emergence of multiple drug resistance in HIV,
with inconsistent conclusions (Bretscher et al., 2004; Althaus and
Bonhoeffer, 2005; Fraser, 2005; Carvajal-Rodriguez et al., 2007;
Kouyos et al., 2009). The most recent of these suggested that both
population dynamics (changing population size) and stochastic-
ity (via the Fisher–Muller effect) have important inﬂuences on
pidemics 14 (2016) 11–25 13
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Fig. 1. Schematic of early HIV-1 adaptation. Illustration showing a viral sequence
consisting of three epitopes with escape mutations e1, e2 and e3 and corresponding
compensatory mutations c1, c2 and c3. Epitopes 1 and 2 are targeted by CTL clones
E and E , whereas epitope 3 is not targeted in this host. The corresponding founder
the total population of CTLs recognizing strain i and/or j asP. Nagaraja et al. / E
he results, clarifying the previous inconsistencies and suggesting
hat recombination tends to have little if any accelerating effect
n the emergence of resistance, especially when positive epistasis
etween mutations is taken into account (Kouyos et al., 2009). The
forementioned studies considered two-locus/two-allele models.
owever, a recent study considering a large number of loci with
tness parameterized empirically suggested that recombination
ould accelerate adaptation of HIV over broad parameter ranges
Moradigaravand et al., 2014). A recent modelling study speciﬁcally
onsidering the role of recombination in immune escape found that
ecombination tends to accelerate escape, with the effect increasing
ith the number of loci involved (Mostowy et al., 2011). The lat-
er study suggested that recombination could have a greater role
hen the cost of escape is smaller, but the main results illustrated
n average over randomly-drawn ﬁtness costs (Mostowy et al.,
011). In the present study, we extend investigations of the role of
ecombination in the adaptation of HIV to a host’s CTL response, by
onsidering in detail the inﬂuence of the ﬁtness landscape. More-
ver, we consider both escape at targeted epitopes and reversion
t non-targeted epitopes, which present distinct features of the
tness landscape. We  investigate these questions using a popu-
ation dynamics model that treats co-infection and recombination
echanistically, and accounts for ﬁnite population effects through
 waiting time for new genotypes to appear.
Our model builds on previous studies that explicitly con-
ider the processes of cellular superinfection, tempered by CD4
own-modulation; the production of novel viral genotypes via
utation and recombination; and/or the dynamics and evolu-
ion of the virus under immune-driven selection (Bretscher et al.,
004; Althaus and Bonhoeffer, 2005; Suryavanshi and Dixit, 2007;
ijay et al., 2008; Arora and Dixit, 2009; Gadhamsetty and Dixit,
010; Mostowy et al., 2011; van Deutekom et al., 2013; Batorsky
t al., 2014). We use a modelling formalism similar to previous
tudies that were able to quantitatively capture in vitro dynam-
cs of the growth of recombinant strains (Suryavanshi and Dixit,
007) and the development of resistance to drugs with large
enetic barriers (Arora and Dixit, 2009). Here, we advance the for-
alism to include the inﬂuence of CTLs in vivo and apply it to
xamine the role of recombination in immune escape and rever-
ion. We  compute the expected waiting times for the emergence
f strains carrying highly adapted combinations of escape and
eversion mutations. We  ﬁnd that recombination may  accelerate or
ecelerate this emergence, depending on the number of epitopes
nvolved in the adaptation process and on the ﬁtness landscape, as
etermined by immune pressure and the cost of escape.
. Model
We  construct a mathematical model to describe within-host
IV-1 evolution in the context of immune pressure from CTLs.
he model consists of a system of ordinary differential equa-
ions describing the dynamics of all viral strains that are present,
ombined with an expected waiting time until mutant strains
ppear, derived from a stochastic process approach. This modelling
pproach is based on the multi-strain viral dynamics model pre-
ented in Arora and Dixit (2009), extended to take into account the
ost’s immune response.
We consider n epitopes on the viral genome undergoing adap-
ation (Fig. 1). ‘Targeted’ epitopes are those newly recognized by
he immune response in the new host, while ‘reverting’ epitopes
re no longer recognized and thus undergoing reversion of muta-
ions ﬁxed in the previous host. On each epitope, we  consider two
ositions at which mutations affect viral ﬁtness, one an escape
utation and the other a compensatory mutation. Thus, a total of
2n different viral variants can arise of which S = 22n − 1 are mutants1 2
sequence and the highly adapted strain are shown with mutations indicated by ‘1’
and wild type alleles indicated by ‘0’.
and one is the wild-type. We  denote the different strains with the
index i where i ∈ {0, 1, . . .,  S}. We  let infection begin with the
founder strain that carries no mutations on the targeted epitopes
and both mutations on each of the reverting epitopes. We  assume
that the most highly adapted strain is the one that carries both
mutations on all the targeted epitopes and none on the reverting
epitopes. (Note that both the founder and highly adapted strains
are generally distinct from the ‘wild type’ which carries no muta-
tions.) We  construct dynamical equations to estimate the time of
emergence of this highly adapted strain.
The equations track the temporal dynamics of populations of
uninfected target cells, T; cells infected with a single provirus i, Ti;
cells infected with two  proviruses i and j, Tij; free virions carrying
genomes i and j, Vij; and CTL effector cells of clone a, Ea, where
i ∈ {0, 1, . . .,  S}, j ∈ {i, i + 1, . . .,  S} and a ∈ {1, 2, . . .,  m}:
dT
dt
=  − dTT − k0T
S∑
i=0
H(t − wi)qi
dTi
dt
= H(t − wi)k0Tqi − k1Ti
(
i−1∑
j=0
H(t − wji)qj +
S∑
j=i
H(t  − wij)qj
)
− ıTi − kCTLTi
m∑
a=1
˛iaEa
h + Gii + Ua
dTii
dt
= H(t − wii)k1Tiqi − ıTii − kCTLTii
m∑
a=1
2˛iaEa
h + Gii + Ua
dTij
dt
= H(t − wij)k1(Tiqj + Tjqi) − ıTij − kCTLTij
m∑
a=1
(˛ia + ˛ja)Ea
h + Gij + Ua
(i /= j)
dVii
dt
= p
(
Ti + Tii +
1
4
i−1∑
j=0
Tji +
1
4
S∑
j=i+1
Tij
)
− cVii
dV ij
dt
= p
2
Tij − cVij (i /= j)
dEa
dt
=  − ıEEa + gEa
S∑
i=0
˛iaTi
Ka + Gii + Ua
+ gEa
S∑
j=0
S∑
k=j
(˛ja + ˛ka)Tjk
Ka + Gjk + Ua
where we  denote the total rate of infection producing provirus i as
qi :=
S∑
j=0
S∑
k=j
Qi(jk)Vjkfjk ;Gij :=
m∑
a=1
(˛ia + ˛ja − ˛ia˛ja)Ea ;
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nd the total population of infected cells (singly or doubly) contain-
ng at least one provirus recognized by effector clone a as
a :=
S∑
j=0
˛jaTj +
S∑
j=0
S∑
k=j
(˛ja + ˛ka − ˛ja˛ka)Tjk .
ere, uninfected CD4+ target cells, T, are produced at the rate 
nd die at the rate dT. Further, uninfected cells are lost to infections
y virions Vjk at the infection rate constant k0 scaled by the rela-
ive infectivity fjk. After infection of a target cell, a virus of type jk
utates and recombines during the process of reverse transcription
roducing provirus i with a probability Qi(jk) (see below).
Singly infected cells are produced from infections of uninfected
ells and are lost to double infections with the rate constant k1,
gain scaled by relative infectivity. They die at the rate ı per day and
re lost due to CTL killing, by recognition of epitopes on their sur-
aces, according to a saturating rate (see below). CTLs recognizing
pitope a, Ea, kill infected cells Ti, Tii and Tij that expose such epi-
opes on their surface. The entries of the binary recognition matrix,
ia, are 1 if Ea recognizes Ti, otherwise 0. We  assume that the killing
fﬁciency is the same for any CTL clone once its target epitope is
ecognized.
In a ﬁnite population, the formation of the infected cell Ti is
tochastic as the rate of infection leading to these cells can be small
or a genome i several mutational steps away from the founder
train. We determine the time to emergence, ti, of the ﬁrst cell Ti
ssuming that infections occur according to a time-inhomogeneous
oisson process. We  denote the expectation of this time to emer-
ence as wi. We  assume, as an approximation, that Ti emerges at
ts expected waiting time, wi (Arora and Dixit, 2009). Thus, if the
ime elapsed from the start of this adaptation process, t, is less than
i, then Ti is yet to be formed, which is captured by the Heavyside
unction: H(t − wi) = 0 if t < wi, otherwise H(t − wi) = 1. A simi-
ar condition applies to the doubly infected cells. The evaluation of
aiting times is described below.
Doubly infected cells are produced from singly infected cells
ith the rate constant k1, lower than k0, as subsequent to single
nfection, CD4 receptors are down-modulated reducing the sus-
eptibility to new infection (Chen et al., 1996; Piguet et al., 1999). If
he same provirus i infects the singly infected cell Ti, then the dou-
ly infected cell Tii is homozygous. If a different provirus j infects
he singly infected cell Ti (or i infects Tj), then the doubly infected
ell Tij is heterozygous. We  ignore more than two  infections per
ell following previous studies (Suryavanshi and Dixit, 2007; Arora
nd Dixit, 2009; Batorsky et al., 2011; Josefsson et al., 2013). We
ssume next that doubly infected cells Tii present epitopes to twice
he extent of singly infected cells Ti, rendering Tii twice as suscep-
ible to CTL killing as Ti. Similarly, the susceptibility of cells Tij to
mmune killing equals the sum of that of Ti and Tj. (Modifying this
ssumption does not alter our qualitative conclusions; see Fig. S1.)
While cells of type Ti and Tii produce only homozygous virions
ii, cells Tij produce virions Vii, Vjj, and the heterozygous virions Vij
n the proportion of 1/4, 1/4, 1/2, representing random assortment
rom a pool of strands i and j (Chen et al., 2009). Infected cells pro-
uce virions at rate p, and virions are cleared at rate c. (We  assume
hat singly and doubly infected cells produce virions at the same
ate, but again, qualitative conclusions are robust to modifying this
ssumption; see Fig. S1.)
Effector cells Ea are produced at an intrinsic rate  and prolifer-
te following their interactions with infected cells at a saturating
ate (see below). The distribution of the saturation parameter
a would deﬁne the immunodominance pattern of the effector
esponse (Mostowy et al., 2011); however, for our results we  will
ake Ka the same for all clones a. The effector cells die at the rate ıE.ics 14 (2016) 11–25
In both CTL proliferation and killing, we employ saturating func-
tional forms, which reﬂect the limitations in the rate of cellular
interactions, for instance due to the time to ﬁnd interacting partners
and the handling time spent in each interaction (Miller et al., 2004;
Beauchemin et al., 2007; Graw and Regoes, 2009; Gadhamsetty
et al., 2014). These considerations imply that interactions cannot
occur at an arbitrarily high rate even as both cellular populations
(infected cells and CTLs) become large, unlike in a mass action func-
tional form. That saturating functional forms are more biologically
realistic has been argued in a recent review on modeling T cell
dynamics (Wodarz, 2014). However, mass action, for instance as
observed in recent studies (Budhu et al., 2010; Ganusov et al., 2011),
can be recovered in the limit as both maximal rates and saturation
parameters become large, i.e., both kCTL and h in the CTL killing term
or both g and Ka in the CTL proliferation term. The functional forms
we use can be derived from kinetic considerations of complex for-
mation and dissociation and making use of the “total quasi-steady
state assumption” (Borghans et al., 1996; De Boer, 2007). Here, sat-
uration occurs with respect to the populations of both interacting
partners. We  note that previous models of immune escape have
also made use of saturating functional forms in CTL proliferation
(De Boer, 2007; Althaus and De Boer, 2008; Mostowy et al., 2011;
van Deutekom et al., 2013; Batorsky et al., 2014) and/or killing
(De Boer, 2007; Althaus and De Boer, 2008; Gadhamsetty et al.,
2014).
We  estimate the values of the parameters involved based on
available experimental/clinical observations and previous mod-
elling studies (see Text S1). The parameter values we use are listed
in Table 1. We  solve the above equations numerically with the
fourth order Runge–Kutta algorithm using a computer program in
C.
2.1. Reverse transcription
We  now describe how we calculate the probability of producing
a given provirus during reverse transcription of a given double-
stranded infecting virion. For this purpose, we follow previous
authors in decoupling mutation and recombination (Boerlijst et al.,
1996; Bocharov et al., 2005; Arora and Dixit, 2009). The proce-
dure closely follows that developed in (Arora and Dixit, 2009). The
probability of producing genome k from genomes j and h via recom-
bination is denoted as Rk(jh), while the probability of producing
genome i via mutation from the recombinant k is denoted by Pik. In
all, 2d different recombinants k, where d is the number of sites at
which j and h differ, can be produced. Summing over the product of
the probability of producing any recombinant k and the probability
of mutating k to i yields the total probability of producing genome
i by reverse transcription of genomes j and h,
Zi(jh) =
2d−1∑
k=0
PikRk(jh)
Whereas the above is the probability of producing a strain i follow-
ing reverse transcription, we recognize in our dynamical equations
that such a strain may  only arise after its waiting time is crossed.
Thus, we determine a normalized probability by restricting the
appearance of proviruses to those genomes whose waiting times
have been crossed, obtaining
Qi(jh) =
H(t − wi)Zi(jh)∑S
k=0H(t − wk)Zk(jh)2.1.1. Recombination
We  begin with genomes j and h that differ at d sites separated
by distances (number of base pairs) l1, l2, . . .,  ld−1. The enzyme
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Table  1
Parameter values used for simulation.
Parameter Description Value
 Inﬂux rate of target cells 2 × 107 cells/day
dT Per capita death rate of uninfected target cells 0.05/day
k0 Infection rate of uninfected cells, per virion and per uninfected cell 10−11/day
k1 Superinfection rate (of already singly-infected cells) 0.7k0 unless otherwise noted
fij Relative infectivity of virus carrying genomes i and j (multiplies k0 and k1) 1 for wild type, variable (<1) otherwise
D* Total death rate of singly infected cells at steady state, assuming susceptibility
to immune killing
1/day
 Steady state proportion of singly infected cell death due to CTL killing,
assuming no escape
Variable
ı Death rate of infected cells due to sources other than CTL killing at the focal
epitope(s)
D*(1 − )
kCTL Maximum rate of CTL killing of singly infected cells Calculated from other parameters (see Suppl. Text S1)
h  Saturation parameter of CTL killing 5 × 108 cells
˛  Binary immune recognition matrix ˛ia = 1 if viral strain i is recognized by CTL clone a, 0 otherwise
  Inﬂux rate of CTLs 20 cells/day
g  Proliferation rate constant of CTLs 1/day unless otherwise noted
Ka Saturation parameter of CTL proliferation for clone a 108 cells
ıE Per capita death rate of effector cells 0.02/day
p  Per capita production rate of virions by infected cells 5 × 104 virions/day
c  Clearance rate of virions 23/day
  Mutation rate 3 × 10−5/site/replication unless otherwise noted
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everse transcriptase (RT) initiates reverse transcription on either
f the two strands with equal probability. Subsequently, RT can
ross over genomes and thus combine genetic material from both
trands in the process. To generate genome k from genomes j and
, RT has to visit these d sites on the appropriate genomes. If RT
erforms an even number of crossovers between successive sites,
hen it remains on the same genome at these sites, otherwise it
hifts to the other genome. If Pdes(x) is the probability that RT is
n the desired genome at the xth distinctive site via odd or even
rossovers over the length lx−1, then the probability of generating
enome k via recombination is
k(jh)  =
d∏
x=1
Pdes(x)
Based on the desired path to generate genome k, at the ﬁrst site
des(1) = 1/2, as RT can start on either genome with equal proba-
ility. If the next desired site on genome k is on the same genome
s the residing genome, then RT has to undergo an even number
f crossovers and hence Pdes(2) = Peven(l1). Otherwise, the desired
ite is on the other genome and RT has to undergo an odd num-
er of crossovers, so that Pdes(2) = Podd(l1). The probabilities Peven(l)
nd Podd(l) are given as (1 + (1 − 2)l)/2 and (1 − (1 − 2)l)/2 respec-
ively, where  is the per site recombination rate of HIV, assuming
 binomial distribution of crossover events over a given number of
ites (see Text S2).
.1.2. Mutation
From the genome k derived from recombination of genomes j
nd h, we obtain the desired genome i by mutation. If genomes i
nd k differ at u sites, then the probability that we  arrive at genome
 from genome k is Pik = u(1 − )2n−u, where 0 ≤ u ≤ 2n and  is the
er site mutation probability..2. Waiting times
The time to emergence, ti, of the ﬁrst singly infected cell Ti can
e modelled by a time-inhomogeneous Poisson process with the8.3 × 10 crossovers/site/replication
variable
S = 22n − 1
instantaneous rate ri(t) of the formation of provirus i (Arora and
Dixit, 2009). The probability that ti is smaller than s is then
P(ti ≤ s) = 1 − exp
(
−
∫ s
0
ri(t)dt
)
, 0 ≤ s < ∞
The expected waiting time for the formation of the ﬁrst singly
infected cell of type i, wi = 〈ti〉 =
∫ ∞
0
s(∂P/∂s)ds or
wi = −
∫ ∞
0
s
∂
∂s
(
exp
(
−
∫ s
0
ri(t)dt
))
ds
Similarly for doubly infected cells, Tij, the expected waiting time for
the ﬁrst formation is
wij = −
∫ ∞
0
s
∂
∂s
(
exp
(
−
∫ s
0
rij(t)dt
))
ds
The required rates are given by:
ri(t) = k0T(t)
S∑
j=0
S∑
k=j
Zi(jk)Vjk(t)fjk ,
rii(t) = k1Ti(t)
S∑
j=0
S∑
k=j
Zi(jk)Vjk(t)fjk ,
rij(t) = k1
(
Ti(t)
S∑
k=0
S∑
l=k
Zj(kl)Vkl(t)fkl + Tj(t)
S∑
k=0
S∑
l=k
Zi(kl)Vkl(t)fkl
)
for i  < j.
To evaluate the above integrals for wi and wij , we follow the numer-
ical procedure developed in (Arora and Dixit, 2009). This procedure
dynamically updates the estimated wi and wij at each time step in
the numerical integration of the ODEs, with the rates calculated
from current population sizes in the system.
3. ResultsWe initialize the system to the steady state where only the
founder strain is present (see Text S1), and focus on the effect of
recombination on the waiting time until the highly adapted strain
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Fig. 2. Fitness landscapes at one epitope. The overall ﬁtness (F) of strains carrying n
nd  compensatory mutations (ec)  are shown. Adaptation can pass through a ﬁtnes
hrough a valley during reversion (right).
rst appears. This effect is quantiﬁed by R = (wrec − wnorec)/wnorec ,
hich is the relative change in this waiting time “with” versus
without” recombination. Thus R < 0 indicates that recombination
as an accelerating effect, while R > 0 indicates a decelerating effect
n adaptation. From an evolutionary theoretical perspective, a
omparison between non-zero crossover probability and the hypo-
hetical scenario of zero crossover probability allows evaluation of
he beneﬁt of recombination to the virus. From a genetics perspec-
ive, the comparison allows investigation of the effect of genome
rchitecture – characterized by the genetic distance between loci
 on viral adaptation, given that it undergoes recombination. In
ractice, for numerical computations, we leave the crossover prob-
bility () ﬁxed and modify the inter-locus distances. In the results
hat follow, we compare approximately free recombination (i.e. a
arge distance) between all or selected loci, to the baseline of com-
lete linkage (zero distance) between all loci. Note that the ordering
f loci does not matter in the two extreme cases of complete or no
inkage between all loci.
.1. Single epitope
We  ﬁrst consider immune escape and reversion at a single
pitope. The pathway of adaptation depends strongly on the under-
ying ﬁtness landscape, which combines intrinsic ﬁtness (mediated
n our model by the relative infectivity, f) and susceptibility to
mmune attack to yield the overall or effective ﬁtness, denoted F.
he effective ﬁtness landscape of the virus, determining the direc-
ion and strength of selection, depends on the current availability of
arget cells and the presence of CTLs recognizing this epitope, and
ill thus generally show complex temporal dynamics (see Text S1).
or intrinsic ﬁtness, we assume fwt > fec > fe, fc; that is, the wild type
train has the highest relative infectivity, while e and c mutations
ome with costs but demonstrate positive epistasis (compensa-
ion). CTLs recognizing a strain affect its survival. If D* is the steady
tate total death rate of singly infected cells and ı the background
eath rate from sources other than killing by CTLs targeting the
ocal epitope, then  = 1 − ı/D* is the proportion of infected cell
eath due to killing by CTLs targeting this epitope. Since the total
eath rate of infected cells is better known than the relative contrib-
tions of background death rate and immune killing (see Text S1),
e ﬁx D* for an immune-susceptible strain, and vary the proportion
f death due to immune killing, . The parameter  thus mediates
he ﬁtness advantage that can be gained by immune escape.
In the escape scenario, where CTLs targeting the epitope are
resent, the founder strain is the wild type carrying no mutations,
enoted wt,  and the highly adapted strain is ec,  carrying both
he escape, e, and compensatory, c, mutations. That is, Fec > Fwt.
urther, Fc < Fwt, representing the ﬁtness penalty associated withtations (wt), an escape mutation (e), a compensatory mutation (c), and both escape
y (solid) or a purely uphill trajectory (dashed) during escape (left), but must pass
the compensatory mutation alone. Although fe < fwt, indicating
the intrinsic ﬁtness loss associated with the escape mutation, Fe
could be greater or smaller than Fwt depending on the strength of
immune killing. If the proportion of death due to immune killing,
, is large, then Fe is likely to be larger than Fwt, owing to the large
ﬁtness gain associated with immune escape. If  is small, however,
Fe is likely to be smaller than Fwt. Thus, depending on  and on f,
and hence on whether Fe is smaller or larger than Fwt, the immune
escape pathway either must pass through a ﬁtness valley or can
access a purely uphill trajectory (Fig. 2A).
In the reversion scenario, CTLs do not target the focal epitope;
thus adaptation occurs under ﬁxed immune pressure on all strains,
which we  suppose is due to CTLs targeting other epitopes (e.g., see
Pandit and de Boer, 2014). Thus, the total death rate is the same
for all strains, and overall ﬁtness is mediated by relative infectiv-
ity. Adaptation therefore always passes through a ﬁtness valley (Fe,
Fc < Fec < Fwt) (Fig. 2B). Note that we  still use e and c to refer to the
mutations, although e does not confer immune escape in the new
host.
Below, we examine the role of recombination in the adaptation
process under each of these circumstances. We  consider a range
of intrinsic ﬁtness landscapes deﬁned by the parameters fe and
fc. In the one-epitope case, the fully adapted strain is two  muta-
tional steps from the founder, and recombination, by potentially
bringing together single-mutants, can thus only have an acceler-
ating effect on its ﬁrst appearance. That is, the direction of the
effect is clear, but the question is its magnitude. Note that once the
highly adapted strain appears, however, recombination can slow
its spread by breaking up the two mutations again, though we  do
not focus on this phase.
3.1.1. Escape
During escape, from the wt strain present initially, the single
mutant genomes e and c are produced by mutations at the same
expected waiting times, as their production rates depend only on
the replication rate of the wt and the mutation rate, and not on
the relative ﬁtness values of the mutants (Figs. 3A and S2). Follow-
ing its emergence, the strain c is competitively suppressed by wt,
because Fc < Fwt, and thus settles to a low frequency. When fe and/or
 are sufﬁciently large such that Fe > Fwt, the strain e has a selective
advantage and can outcompete the wt.  It thus rises rapidly follow-
ing its emergence. When, as a consequence, the e strain becomes
dominant, the rate at which the ec strain arises by mutation of the
e strain is much larger than by recombination between the e and
c strains. Recombination, therefore, plays a negligible role in the
emergence of the ec strain under these circumstances. That is, the
expected waiting time of the highly adapted (ec) strain with and
without recombination is similar, wrec ≈ wnorec ≈ 5 days (fe = 0.8 in
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Fig. 3. Escape and reversion at a single epitope. We set the intrinsic ﬁtness of the founder strain (fwt) to 1 and the highly adapted strain (fec) to 0.9 throughout, and vary
the  intrinsic ﬁtness associated with escape (fe) and compensatory (fc) mutations. The relative contribution of immune killing is  = 0.9. Other parameter values are listed in
Table 1. (A) Temporal dynamics of escape at a single epitope for varying intrinsic ﬁtness values of the escape strain (given by fe in the legend on each panel). Populations of
singly  infected cells with proviruses wt,  e, c and ec (top panel) and populations of doubly infected cells carrying proviruses e and c (red) and various other pairs of proviruses
(grey) (bottom panel). Solid lines indicate dynamics without recombination and dashed lines with recombination. (B) The percentage change in the expected waiting time
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ig. 3A), so that our measure of the inﬂuence of recombination,
 = (wrec − wnorec)/wnorec , is nearly zero. If, on the other hand, fe is
maller, so that Fe ≈ Fwt, then e does not have a signiﬁcant advan-
age over wt,  but the rate at which it superinfects cells infected by
 remains signiﬁcant. Then recombination can accelerate the accu-
ulation of the two mutations and hence the emergence of the
c strain (wrec ≈ 12 days and wnorec ≈ 13.5 days so that R ≈ −12%,
hen fe = 0.2 in Fig. 3A). If fe is too low, then e settles to such a low
requency that coinfection of cells by e and c becomes rare, and
ecombination again does not accelerate escape (wrec ≈ wnorec ≈
0 days, so that R ≈ 0% when fe = 0 in Fig. 3A). Similar trends are
bserved as fc is altered for ﬁxed fe. Fig. 3B illustrates how R varies
cross the full range of fe and fc.
We  examine next the inﬂuence of parameter variations on the
ffect of recombination, as quantiﬁed by R. Increasing the frequency
f doubly infected cells, by increasing the superinfection rate k1 of
ingly infected cells, enhances the effect of recombination (Fig. S3).
or smaller mutation rates (), the relative inﬂuence of recombina-
ion is also larger (Fig. S4A), while for large values of , the inﬂuence
f recombination is overwhelmed by mutation and R is zero acrosse and compensatory mutations for the cases of escape (left) and reversion (right).
 web  version of this article.)
the ﬁtness landscape (Fig. S4B). Decreasing the relative contribu-
tion of immune killing to infected cell death () lowers the ﬁtness
advantage associated with escape and hence the uphill immune
escape pathway only becomes accessible at higher intrinsic ﬁtness
of the escape strain. Thus, while the qualitative pattern described
above remains similar, the accelerating effect of recombination is
evident at correspondingly higher values of fe when  is smaller
(Fig. S5).
3.1.2. Reversion
We  next consider the reversion of an escape mutant in a new
host. Here, we begin with the ec strain. Both the single mutant e
and c strains again arise due to mutation of the ec strain. Because
the ﬁtness landscape always passes through a valley, they both
remain at low frequencies relative to the ec strain. The rate at
which cellular superinfection with the e and c strains occurs is thus
substantially smaller than superinfection with the ec strain. Conse-
quently, the production of heterozygous virions, which provide the
substrate for recombination, is minimal. R thus remains nearly zero
throughout the ﬁtness landscape, until fe and fc become comparable
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o fec, which here is set to 0.9 (Fig. 3B). Recombination thus does
ot have a signiﬁcant effect on reversion associated with a single
pitope. This result is robust to variations in the parameters k1, ,
nd  (Figs. S3–S5).
.2. Two epitopes
We  now consider adaptation at two epitopes. At each epitope,
e let mutations affect intrinsic ﬁtness as deﬁned in the single epi-
ope case above. Thus, fe1 is the intrinsic ﬁtness of the single mutant
train carrying the escape mutation on the ﬁrst epitope. For sim-
licity, we assume that the intrinsic ﬁtness landscapes governing
he two epitopes are identical, so that fe1 = fe2 , and so on. We thus
solate the effect of simply having more sites at which adaptive
hanges are required. Further, we assume that the intrinsic ﬁtness
ffects exhibit no inter-epitope epistatic interactions, so that, e.g.,
e1e2 = fe1 fe2 .
To examine the inﬂuence of recombination, we  consider two
rrangements of loci. In the ﬁrst, the escape and compensatory
utations are all sufﬁciently far apart on the genome to allow
aximal recombination between all loci. In the second, the escape
nd compensatory mutations associated with a given epitope are
roximally located but the epitopes are far apart, so that recombi-
ation has no inﬂuence on adaptation at any one epitope, but can
xert its inﬂuence across the epitopes. For each scenario, we  again
xplore the inﬂuence of recombination across a range of intrinsic
tness landscapes deﬁned by the parameters fe (= fe1 = fe2 ) and
c (= fc1 = fc2 ). Three cases arise: (1) escape at both epitopes, (2)
eversion at both epitopes, and (3) escape at one and reversion at
he other epitope.
.2.1. Escape at both epitopes
In this case, the founder strain is the wild type, wt.  We  exam-
ne the effect of recombination on the expected waiting time for
he strain that accumulates escape and compensatory mutations
t both epitopes, denoted e1c1e2c2, where the subscripts indicate
he epitope number.
In contrast to the single epitope results, we ﬁnd here that recom-
ination can accelerate or decelerate adaptation (measured again
y R = (wrec − wnorec)/wnorec , where w is the waiting time for the
ppearance of the highly adapted strain, here e1c1e2c2) depend-
ng on the underlying ﬁtness landscape (Fig. 4A). For instance, for
he chosen parameter values, as fe increases with fc ﬁxed, recom-
ination exhibits a complex, non-monotonic inﬂuence. We  can
nderstand these effects by again looking at temporal dynamics,
llustrated in Fig. 5 for the example where fc = 0.4 and fe varies from
.4 to 0.7. Note that by symmetry, the two epitopes are interchange-
ble, and thus the corresponding strains (e.g. e1c1 and e2c2) have
dentical dynamics.
Starting from the wt strain, all single mutant strains (e1, c1,
2, and c2) are produced at the same expected time. The strains
owever settle to low frequencies given their poor ﬁtness rela-
ive to wt.  Because Fe > Fc in this example (due to the advantage
f escaping at one epitope and given that fe ≥ fc here), the e1 and e2
trains are slightly higher in prevalence than c1 and c2, and their
revalence increases with fe across panels. The double mutant e1e2
ppears next, closely followed by e1c1 and e2c2. Due to the lower
tness of c, the double mutant c1c2 appears somewhat later and
emains at very low frequencies, thus playing a negligible role in the
ynamics. Though recombination among the corresponding single
utants could potentially play a role in the emergence of the double
utants, it appears that this effect is minimal.
Under the chosen parameter settings (fec = 0.9, combined with
he advantage of escape at one epitope), e1c1 and e2c2 are ﬁtter
han wt and thus grow. Here, recombination inhibits their growth
ecause recombination predominantly occurs with the wild type,ics 14 (2016) 11–25
breaking each ec into its constituent single mutants. The effect is
evident in the signiﬁcantly delayed emergence of all triple mutant
strains in the presence of recombination. Nonetheless, the possibil-
ity of recombining e1c1 and e2c2 to produce the desired quadruple
mutant e1c1e2c2 points to a counteracting advantage of recombi-
nation.
The net effect of recombination varies with fe across the pan-
els. (Note that as fe increases, the quadruple mutant emerges faster
in absolute terms, either with or without recombination; however,
we focus on the relative effect of recombination, as quantiﬁed by
R, for each fe.) This variation can be traced to the dynamics of the
strains e1e2, e1c1e2, and e1e2c2, which depend on fe. When fe = 0.4
(Fig. 5A), the aforementioned double mutant does not rise in fre-
quency, and the triple mutants rise relatively slowly due to only a
small advantage over wt.  Recombination plays a signiﬁcant role
in bringing together e1c1 and e2c2 to accelerate the appearance
of e1c1e2c2 (R ≈ −20%). When fe = 0.5 (Fig. 5B), the triple mutants
rise faster and the rate of production of e1c1e2c2 by one additional
mutation is larger. Consequently, the relative role of recombina-
tion declines (R ≈ −5%). Once fe = 0.6 (Fig. 5C), the double mutant
e1e2 also becomes signiﬁcantly ﬁtter than the wt  and thus rises in
frequency. The predominant pathway of adaptation now begins to
shift from being dominated by the accumulation of mutations on
the e1c1 and e2c2 backgrounds to that on the e1e2 background. Once
the triple mutants e1c1e2 and e1e2c2 appear, recombination can
bring them together to produce the quadruple mutant. However,
the inhibitory effect of recombination in breaking up the double
mutant strains (through recombination with wt)  is also evident,
delaying the emergence of the triple mutants. The net effect of
recombination on the emergence of the quadruple mutant becomes
inhibitory (R ≈ 10%). As fe increases further to 0.7 (Fig. 5D), the
intermediate strains e1e2, e1c1e2, and e1e2c2 all rise rapidly after
their appearance, and the emergence of e1c1e2c2 through sequen-
tial accumulation of mutations swamps the effect of recombination.
The net effect of recombination remains inhibitory here, but is sub-
dued to R ≈ 5%.
When free recombination occurs only between the two epi-
topes while the escape and compensatory mutations associated
with each epitope are tightly linked, recombination tends to have a
more beneﬁcial (or less inhibitory) effect on the emergence of the
quadruple mutant throughout (Fig. 4A). Essentially, this is because
we eliminate the detrimental effect of recombination in break-
ing up e from c at each epitope by recombination with the wild
type, while leaving its main beneﬁt of bringing together e1c1 and
e2c2 intact. Only at the highest fe does sequential mutation swamp
recombination and R ≈ 0.
Decreasing the relative strength of immune killing () shifts the
balance increasingly toward the inhibitory effects of recombination
when recombination is allowed between all loci (Figs. S6A and S6B).
As  decreases, and correspondingly the background death rate
is higher, the overall ﬁtness values Fe and Fec of strains carrying
escape mutations decrease for the same intrinsic ﬁtness values fe
and fec. This reduced ﬁtness implies that e1c1 and e2c2 are present at
reduced frequencies, and when recombination is allowed, it occurs
primarily with the wild type. When  is small, recombination thus
inhibits the growth of e1c1 and e2c2 by breaking up the two combi-
nations (Fig. S7), while co-infection with both e1c1 and e2c2 is rare
and therefore recombination can play only a small role in bringing
these two pairs of mutations together. Consequently, recombina-
tion decelerates the emergence of the quadruple mutant when
maximal recombination between all loci is allowed (Fig. S6B). When
only inter-epitope recombination occurs, recombination remains
beneﬁcial (with even a slightly increased magnitude) over most of
the range, but the inhibitory effect seen at high fe becomes stronger.
As there is uncertainty in the parameters of CTL dynamics, we
also consider different values of the CTL proliferation rate, g (see
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Fig. 4. Escape and reversion at two  epitopes. We set the intrinsic ﬁtness of the founder strain (fwt) to 1 and the adapted strain (fec) to 0.9 throughout, and vary the intrinsic
ﬁtness  associated with escape (fe) and compensatory (fc) mutations. The relative contribution of immune killing is  = 0.9. Other parameter values are listed in Table 1.  The
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percentage change in the expected waiting time for the emergence of the fully ad
ubject to immune escape, (B) both subject to reversion, (C) one subject to escape an
oth  within and between epitopes. The right panel illustrates the case when recom
ext S1). Increasing g implies a higher CTL population before the
tart of escape. (Note that keeping  constant requires a corre-
pondingly lower per capita CTL killing rate (kCTL).) The net CTL
illing rate rises with the CTL population and eventually saturates.
ollowing the emergence of the strain carrying escape and com-
ensatory mutations at one epitope, it is targeted by a smaller
opulation of CTLs that continue to recognize the other epitope. strain with versus without recombination (R * 100%) when (A) both epitopes are
other to reversion. The left panel illustrates the case when recombination can occur
on can occur between epitopes but not within epitopes.
With higher g, this reduced population leads to a much smaller
decline in the net CTL killing rate due to saturation effects, and
hence slower growth, than with smaller g (Fig. S8; compare with
Fig. 5). The effect of recombination when g is increased with ﬁxed 
(Fig. S9A) is similar to that when  is lowered with ﬁxed g (Fig. S6B),
which also leads to lower growth due to greater non-speciﬁc killing
(Fig. S7; compare with Figs. 5 and S8). Correspondingly, decreasing
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Fig. 5. Dynamics of escape at two  epitopes. Time evolution of populations of various singly infected cells for selected intrinsic ﬁtness values of the escape mutation, as
i s) or w
s  thus 
g
(
3
a
r
tndicated in each panel, with maximal recombination between all loci (dashed line
ame  as in Fig. 4A. Note that by symmetry the two  epitopes are interchangeable, and
 renders recombination beneﬁcial over larger ranges of fe and fc
Figs. S9B and S9C).
.2.2. Reversion at both epitopes
Reversion of ec at any given epitope involves passing through
 ﬁtness valley (i.e. a single mutation, here the loss of e or c alone,
educes ﬁtness) to a higher peak on the other side (i.e. two  muta-
ions, here the loss of both e and c, increases ﬁtness relative to theithout recombination (solid lines). The other parameter values employed are the
the corresponding strains (e.g., e1 and e2, or e1c1 and e2c2) have identical dynamics.
founder). Thus reversion at two  epitopes involves adaptation on
a ﬁtness landscape similar to the case of escape at two  epitopes
with low fe (creating a ﬁtness valley at each epitope) and high 
(implying elevated ﬁtness of the double mutant at each epitope).
The outcome is thus also similar: recombination uniformly acceler-
ates reversion at two  epitopes (Fig. 4B). Starting with the quadruple
mutant (e1c1e2c2), the triple mutants are produced ﬁrst. The double
mutants are produced next, of which the e1c1 and e2c2 strains grow
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ue to elevated ﬁtness (Fig. S10). Recombination with the quadru-
le mutant slows their rise by breaking them into their precursor
riple mutants. At the same time, recombination can bring the two
ouble mutants together and produce the wild-type, completing
he reversion process. The latter effect of recombination predomi-
ates, resulting in the net beneﬁt of recombination to reversion at
wo symmetrical epitopes.
Again, if recombination only occurs between epitopes and is
hus unable to break the escape and compensatory mutations
ithin an epitope, its inhibitory effect is suppressed and a greater
cceleration of reversion is observed. Further, as all strains are
ssumed equally susceptible to immune killing in the reversion
rocess, altering  or g (not shown) alters the inﬂuence of recom-
ination only marginally (Fig. S11).
.2.3. Escape at one and reversion at the other epitope
When escape at one and reversion at the other epitope are
nvolved, the effects of recombination appear as a composite of the
ffects observed above with escape and reversion at both epitopes.
ow, supposing epitope 1 is targeted and epitope 2 is reverting,
daptation begins with the founder strain e2c2, with both escape
nd compensatory mutations on the reverting epitope and none on
he targeted epitope. We  follow the adaptation until the emergence
f the highly adapted e1c1 strain where both escape and reversion
re complete. Although we assume that the intrinsic ﬁtness land-
cape is identical for the two epitopes, the targeted epitope has
uperimposed on this landscape pressure from the immune system,
nd thus the overall ﬁtness landscapes of the two  epitopes differ.
onsequently, evolution at the two epitopes does not proceed sym-
etrically, unlike the cases above. For instance, the single mutants
1 and e2 now have different ﬁtnesses and thus follow different
ynamics, introducing an additional dimension of inter-epitope
ompetition.
The reverting epitope undergoes adaptation on a ﬁtness land-
cape that contains a valley. Consequently, single mutations at
his epitope remain at low frequencies, whereas the wt once it
ppears can outcompete the founder. The targeted epitope, on
he other hand, either must pass through a ﬁtness valley or may
ccess a purely uphill trajectory depending on fe. In the former case,
he e1e2c2 and c1e2c2 strains arise but remain at low frequencies,
hereas in the latter case, e1e2c2 can grow. An additional muta-
ion gives rise to the e1c1e2c2 strain. The subsequent growth of the
t and e1c1e2c2 are inﬂuenced by recombination and the ﬁtness
dvantage gained by immune escape. The wt always enjoys a ﬁtness
dvantage relative to the founder strain, whereas the quadruple
utant has a ﬁtness advantage only when  is sufﬁciently high.
he growth of both strains can be inhibited by recombination with
he founder strain, but recombination with one another can pro-
uce the highly adapted e1c1 strain (Fig. S12). Accordingly, when
 is large, recombination accelerates adaptation (Fig. 4C). As 
ecreases, the beneﬁt of recombination to adaptation diminishes
Fig. S13A), and eventually recombination becomes detrimental
Fig. S13B). When recombination within epitopes does not occur,
he ec combinations are not split, so that recombination always
eneﬁts adaptation (Fig. S13A and S13B). In all cases, the inﬂuence
f recombination is intermediate to that in the scenarios involving
scape or reversion at both epitopes.
. Discussion
Early adaptation of HIV-1 following its transmission typically
ombines the acquisition of escape mutations at epitopes targeted
y CTLs in the new host and the reversion of mutations in the
ransmitted viral genome at epitopes that were targets in the donor
ut not in the new host. Despite the large mutation and turnoverics 14 (2016) 11–25 21
rates of HIV, mutation may  prove inadequate as the sole driving
force for this adaptation: the potential ﬁtness loss upon acquir-
ing escape or compensatory mutations alone, together with clonal
interference among strains that have adapted at different epitopes,
inhibits the accumulation of the requisite adaptive mutations at
multiple loci. Recombination may  then play an important role in
accelerating this adaptation, under circumstances that we clariﬁed
here.
Using a detailed model of viral dynamics combining immune
response by CTLs and viral evolution driven by mutation, recombi-
nation and selection, we  investigated the expected waiting time for
the appearance of the highly adapted strain, carrying all of the req-
uisite mutations, in the presence and absence of recombination. We
ﬁnd, interestingly, that the dominant pathway of adaptation can
differ substantially based on the underlying ﬁtness landscape and
that recombination can have opposite net inﬂuences on adaptation
depending on the pathway involved. We  summarize our ﬁndings
using the scenario where adaptation involves immune escape at
two identical epitopes (Fig. 6). If escape mutations carry a sig-
niﬁcant ﬁtness penalty, then adaptation at each epitope passes
through a ﬁtness valley on the way  to the ec double mutants. Sub-
sequently, recombination can separate the double mutants into
their constituent e and c single mutants, slowing adaptation. At
the same time, it can bring the two double mutants together to
yield the highly adapted quadruple mutant. So long as immune
escape at each epitope confers a sufﬁcient beneﬁt, so that the
ec double mutants reach high enough frequency for substantial
coinfection together, the latter effect dominates and recombina-
tion accelerates adaptation (Fig. 6A). If however immune escape
at one epitope does not confer a sufﬁcient beneﬁt (which is the
case if CTL killing contributes little to total infected cell death), the
ec double mutants remain at lower frequency and coinfection is
primarily with the wild type, so that the former effect dominates
and recombination decelerates adaptation. Of course, if the e and c
mutations on each epitope are proximally located and hence tightly
linked, then recombination is ineffective in separating the double
mutants, so that its overall effect tends to be beneﬁcial (or less
detrimental).
If escape mutations have an overall ﬁtness advantage alone
(even without compensation), adaptation at each epitope can
proceed on a purely uphill trajectory. The e mutants then grow,
yielding the double mutant e1e2. Adaptation now proceeds on
the background of the e1e2 strain rather than the ec strains as
above. Since c1c2 is of low ﬁtness and thus rare, recombination
bringing together e1e2 and c1c2 is negligible. The predominant
effect of recombination is thus to separate the e1e2 double mutant,
delaying the emergence of triple mutants and hence further adap-
tation (Fig. 6B). This delay outweighs the subsequent possibility
for recombination to accelerate adaptation by bringing the triple
mutants together.
To summarize, when adaptation passes through a ﬁtness valley
to a sufﬁciently high ﬁtness gain at each epitope, recombination
acting between epitopes brings well-adapted pairs of mutations
together and has the net effect of accelerating adaptation. When
an uphill trajectory is accessible at each epitope, the primary
role of recombination is to separate mutations on the dominant
intermediate double mutant, delaying subsequent adaptation. This
difference in the dominant adaptation pathway underlies the dif-
ferent roles of recombination we observed for immune escape
versus reversion at multiple symmetrical epitopes. While rever-
sion occurs on the former type of landscape, escape could fall into
either scenario, depending on the intrinsic ﬁtness cost of escape
mutations (which is observed to vary widely; see e.g. Troyer et al.,
2009) and the extent to which escape reduces total infected cell
death (which is not well known). Our results can also be inter-
preted in terms of the distances between loci that maximize rate of
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Fig. 6. Illustration of the inﬂuence of recombination on early HIV-1 adaptation, speciﬁcally the scenario of escape at two  epitopes. The height of each bar indicates the overall
ﬁtness  (F) of the corresponding strain. (A) Case where Fe is small but Fec is high (due to low fe while  is sufﬁciently high) and a ﬁtness valley at each epitope must be crossed
(cf.  dynamics in Fig. 5A). (B) Case where Fe is large (due to high fe) and adaptation can proceed by a purely uphill ﬁtness trajectory at each epitope (cf. dynamics in Fig. 5C).
Only  major pathways of mutation (solid arrows) and recombination (dashed arrows) are shown, with the most signiﬁcant recombination pathways highlighted with thicker
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daptation: while linkage between various escape mutations may
e beneﬁcial or detrimental, depending as described on the ﬁtness
andscape, tight linkage between a given escape mutation and its
ssociated compensatory mutation (which exhibits positive epista-
is) appears to be generally beneﬁcial for multi-epitope adaptation.
t appears that associated escape and compensatory mutations are
ften close together, though not necessarily within the same epi-
ope (Brockman et al., 2007; Crawford et al., 2007; Schneidewind
t al., 2007; Wright et al., 2012; Liu et al., 2014). Generally speak-
ng, our study predicts that both ﬁtness effects (costs and beneﬁts)
nd linkage patterns among loci involved in adaptation are crucial
arameters. Further empirical work to quantify these parameters
ould clarify which scenario is most frequently faced by HIV, and
hus help resolve the ambiguous evolutionary advantage of under-
oing recombination.
In the present study, we have restricted our analysis to a max-
mum of two epitopes (thus four loci). With two epitopes, the
ffects of recombination in both bringing together and breaking
p mutations, thus affecting both appearance and growth of inter-
ediate strains, already become evident, while the system still
emains amenable to efﬁcient computation and a thorough under-
tanding of dynamics. Our model is nonetheless constructed moren with an arrow only from the higher- to lower-order mutant, i.e. not illustrating
1c2, c1e2, c1c2) and triple mutants (e1c1c2, c1e2c2) which play a minimal role in the
generally and can be applied to adaptation at more than two
epitopes. We  expect computational speed, however, to become
prohibitive beyond three or four epitopes, in which case it would
be worthwhile to investigate approximations to certain processes
in the model. If more reverting epitopes with similar ﬁtness
effects are considered, we anticipate, based on our one- and two-
epitope results, that recombination is likely to expedite adaptation.
If more targeted (escaping) epitopes are considered, the inﬂu-
ence of recombination would depend on the ﬁtness landscape, as
determined by both the intrinsic replicative capacity and the rela-
tive contribution of immune killing. Unequal ﬁtness effects across
adapting epitopes could add further nuances to these results. A pre-
vious study, using a less detailed model with a heuristic description
of recombination, considered up to 15 targeted epitopes and pre-
dicted that recombination has an increasingly accelerating effect
on adaptation as the number of epitopes increases (Mostowy et al.,
2011). However, averaging results over randomly drawn ﬁtness
costs of escape in that study precluded such a detailed under-
standing of the role of the ﬁtness landscape as we achieved here.
We recognize though that as the number of epitopes increases, it
may  become increasingly important to account for ﬁtness interac-
tions among epitopes. More realistic ﬁtness landscapes of HIV-1,
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ncluding epistatic interactions, are beginning to be unraveled
Hinkley et al., 2011; Ferguson et al., 2013).
Some modelling studies of SIV infection in rhesus macaques
llude to antibody dynamics during acute infection (Vaidya et al.,
010). While antibodies appear within the ﬁrst few weeks of infec-
ion, they do not seem to have a signiﬁcant effect on viremia.
ntibodies with signiﬁcant neutralizing activity emerge only after
everal months to years past the acute infection stage (Overbaugh
nd Morris, 2012). In contrast, a median of eight epitopes are tar-
eted by CTLs within three months from the onset of symptoms
Turnbull et al., 2009), and CTL responses are strongly associated
ith several orders of magnitude decline in viremia (Walker and
cMichael, 2012). We  have therefore focused on adaptation in
he context of CTL responses. Furthermore, we investigated a rel-
tively simplistic immune response, in which we assumed that
ll effector clones behave identically and begin at their steady-
tate levels. We  did not deal with different CTL avidities, leading
o immunodominance patterns, or different killing efﬁciencies at
ifferent epitopes. Previous modelling studies have indicated that
symmetries among effector cell clones can affect escape dynamics
Althaus and De Boer, 2008; Mostowy et al., 2011; van Deutekom
t al., 2013), and that the more realistic scenario in which escape
utations may  only partially abrogate CTL killing affects the rise of
hese mutations (Batorsky et al., 2014). Furthermore, in the two-
pitope studies, we assumed the intrinsic ﬁtness effects at the two
pitopes to be identical. This assumption helps in delineating the
nﬂuence of recombination on multi-locus adaptation while keep-
ng the complexities of clonal interference to a minimum. Fitness
ffects, however, are unlikely to be identical at any two  epitopes.
his asymmetry is considered in our study in the case where one
pitope is escaping and the other is reverting, such that the two
pitopes then have different overall ﬁtness landscapes. Further
xploration of the effects of both epitope asymmetries and more
omplex immune responses using our model in its general form
ould provide interesting directions for future work. Finally, CTL
illing efﬁciencies can be compromised by T cell exhaustion, a phe-
omenon of great current interest (Wherry and Kurachi, 2015).
ollowing the formalism proposed by Johnson et al. (2011), where
he level of exhaustion is determined by the level of cumulative
ntigenic stimulation, we found over a range of parameter values
ncompassing those employed in the latter study that exhaustion
id not alter the inﬂuence of recombination we predict (not shown).
hus, it appears that the general effects of recombination we  found
re fairly robust. However, a full exploration of the effects of dif-
erent models of CTL response are beyond the scope of the present
tudy.
Our model in its present form is fully deterministic, allowing
eady exploration of parameter space and rendering it amenable
o data analysis. Unlike many deterministic models, however, it
as the advantage of capturing delays in the emergence of mutant
trains in a ﬁnite population, which enables it to capture the
isher–Muller effect. Indeed, a similar formalism in the context of
rug resistance, based on which the current study is built, quantita-
ively captured the in vitro development of resistance to tipranavir,
n HIV protease inhibitor with a large genetic barrier (Arora and
ixit, 2009). A limitation of the formalism is that stochastic varia-
ions around the mean are ignored, though these may  contribute
ubstantially to immune escape and control (Read et al., 2012;
essinger et al., 2013). In particular, in a stochastic setting, strains
equiring the same number of mutational steps may  appear at dif-
erent times, and strains with the same expected ﬁtness may  vary
n their growth. This will affect the availability of relevant strains
or recombination, even if we continue to assume identical ﬁtness
ffects across epitopes.
While still removed from making speciﬁc clinical sugges-
ions, our results have general implications for understanding andics 14 (2016) 11–25 23
managing HIV. Firstly, the substantial effect of recombination on
adaptation rate that we  predict indicates that linkage patterns
among adapting loci should be taken into account in the design
of a T-cell vaccine targeting multiple epitopes. Though the focus
on targeting conserved sites where mutations carry large costs
(Martinez-Picado et al., 2006; Schneidewind et al., 2007; Goepfert
et al., 2008; Dahirel et al., 2011) is justiﬁed, an additional mod-
erating factor could be the distances between predicted escape
mutations as well as their associated compensatory mutations.
Secondly, the inﬂuence of recombination has implications for quan-
tifying the timing and rate of escape from patient data, currently
an active research area (Asquith et al., 2006; Ganusov et al., 2006,
2011, 2013; Kessinger et al., 2013; Pandit and de Boer, 2014; Garcia
and Regoes, 2014). Most models used for this purpose have treated
each escape locus independently (Asquith et al., 2006; Ganusov
et al., 2006, 2011). Recent results indicate that clonal interference
is expected to bias estimates of escape rates based on individual
sites (Ganusov et al., 2013; Kessinger et al., 2013; Pandit and de
Boer, 2014; Garcia and Regoes, 2014), and an inference method for
multi-locus data assuming complete linkage (no recombination)
has recently been developed (Kessinger et al., 2013). Our results
clarify the potentially signiﬁcant effect of recombination on the
timing at which new strains arise and how fast they spread. With
growing availability of haplotype data that preserves information
about linkage of escape mutations (e.g. Henn et al., 2012), our work
emphasizes the need for further development of inference methods
that take recombination into account.
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